Raleigh-Durham, North Carolina, United States, October 2024 – Kelli Miller has been appointed as the Head of Global Human Resources at Emmes Group, a leading organization dedicated to advancing public health and biopharmaceutical innovation. Kelli will oversee HR operations globally, bringing her extensive experience in HR strategy, business transformation, and leadership development to Emmes as the organization continues to evolve in the clinical research and artificial intelligence sectors.
Prior to this role, Kelli Miller served as Senior Vice President, HR & Business Transformation at Veridix AI, part of Emmes Group, for 10 months, where she led HR initiatives and business transformation strategies aimed at integrating human and artificial intelligence for clinical trial infrastructure advancements.
Before joining Veridix AI, Kelli held various roles at Emmes, including Senior Vice President, Human Resources, and Vice President, HR Operations. During her 1.5 years with Emmes, she played a key role in HR leadership, overseeing operations and supporting global HR initiatives that drove organizational effectiveness.
Earlier, Kelli was Senior Director of HR at IQVIA for over 2 years, where she implemented HR strategies focused on talent acquisition, employee engagement, and performance management across a large, multinational workforce.
Kelli also spent 7.5 years at Clinipace Worldwide, serving in roles such as Vice President, Global Human Resources and Sr. Director, Global Human Resources, where she managed global HR functions for a growing clinical research organization, driving significant improvements in HR processes, compliance, and talent management.
About Emmes Group:
Emmes Group is a global leader in biopharmaceutical innovation and clinical research. Founded in 1977, the organization operates through its CRO (Contract Research Organization) arm, Emmes, which provides clinical services to both public and private sectors. Additionally, its Veridix AI division focuses on artificial intelligence-driven solutions designed to revolutionize clinical trial infrastructure for the 21st century. Emmes Group’s mission is to advance public health through the convergence of human intelligence and artificial intelligence, making impactful contributions to medical research and innovation worldwide.
Read Also : Imagination in a Disrupted Age: Navigating the Future with Curiosity and Empathy
